John Raymond Murphy, Director at Cadrenal Therapeutics, Inc. (CVKD), bought 20,000 shares at $1.67 ($33K) on 2023-03-16, disclosed to the SEC on 2023-03-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ORLY | SELL | 2025-05-20 | $276K | — | Filing → |
| ORLY | SELL | 2024-02-15 | $559K | — | Filing → |
| ORLY | SELL | 2023-11-02 | $465K | — | Filing → |